Clinical Trial Update: A Randomised, Double-Blind, Placebo-Controlled Study Evaluating the Efficacy and Safety of Orvepitant in Subjects With Major Depressive Disorder [Phase 2]

View source ↗

Summary

A Phase 2 randomized, double-blind, placebo-controlled study evaluating Orvepitant for major depressive disorder was terminated. Results were posted on 2017-10-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Orvepitant (Orvepitant)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Depressive Disorder | Phase 2 | Status: TERMINATED | Results posted: 2017-10-13